AA
RBOT

AlphaCentric Advisors’s Vicarious Surgical RBOT Stock Holding History

AlphaCentric Advisors’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,833
Closed -$320K – 253
2023
Q2 		$320K Hold
5,833
– – 0.18% 111
2023
Q1 		$397K Buy
5,833
+833
+17% +$64.8K 0.27% 97
2022
Q4 		$303K Buy
5,000
+2,333
+87% +$217K 0.3% 94
2022
Q3 		$268K Buy
+2,667
New +$311K 0.28% 82
2021
Q3 		– Sell
-1,833
Closed -$548K – 215
2021
Q2 		$548K Buy
+1,833
New +$546K 0.15% 57

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

AlphaCentric Advisors's RBOT Position: Q3 2023 in Review

AlphaCentric Advisors sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 5,833 shares — an estimated $320K sold.

AlphaCentric Advisors first reported a position in RBOT in Q2 2021 and held it in 5 quarters. The position peaked at $548K in Q2 2021. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • AlphaCentric Advisors reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
  • AlphaCentric Advisors sold 5,833 Vicarious Surgical shares in Q3 2023, an estimated $320K.
  • AlphaCentric Advisors first reported a position in Vicarious Surgical in Q2 2021 and held it in 5 quarters.
  • AlphaCentric Advisors's Vicarious Surgical position peaked at $548K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.